Hyderabad Telangana, India

Naga Venkata Durga Prasad Ketha

USPTO Granted Patents = 5 

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Naga Venkata Durga Prasad Ketha: Innovator in Pharmaceutical Compositions

Introduction

Naga Venkata Durga Prasad Ketha is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of stable liquid compositions of clonidine. With a total of five patents to his name, his work has the potential to impact the treatment of various diseases.

Latest Patents

One of his latest patents focuses on stable pharmaceutical compositions of clonidine. This invention relates to liquid pharmaceutical compositions of clonidine or its pharmaceutically acceptable salts. The compositions are designed for oral administration and are stable for extended periods. Specifically, these stable liquid pharmaceutical compositions of clonidine are provided at concentrations of 1 μg/mL or more. The invention also includes methods for administration, processes for production, and the use of these compositions for treating diseases that are responsive to clonidine.

Career Highlights

Throughout his career, Naga Venkata Durga Prasad Ketha has worked with reputable companies in the pharmaceutical industry. He has been associated with Slayback Pharma LLC and Azurity Pharmaceuticals, Inc., where he has contributed to innovative projects and advancements in drug formulations.

Collaborations

He has collaborated with several professionals in the field, including Sumitra Ashokkumar Pillai and Shailendra Mandge. These collaborations have further enhanced his research and development efforts in pharmaceutical innovations.

Conclusion

Naga Venkata Durga Prasad Ketha is a distinguished inventor whose work in stable pharmaceutical compositions has the potential to improve treatment options for patients. His contributions to the field of pharmaceuticals are noteworthy and reflect his commitment to innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…